Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Evidence and Multi-omics Insights Into Differential Immunotherapy Responses Between Primary and Metastatic Sites

NCT07631611 is registered in ClinicalTrials.gov with Wenlong Zhong, MD as lead sponsor.

NCT NCT07631611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07631611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Evidence and Multi-omics Insights Into Differential Immunotherapy Responses Between Primary and Metastatic Sites
Lead sponsor
Wenlong Zhong, MD
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
May 20, 2026
Enrollment
938 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis, immune checkpoint inhibitors, metastatic cancer to liver, metastatic cancer to the bone, metastatic cancer to the lung, metastatic cancers, solid tumors, tumor immune microenvironment